Neuropsychological outcome after deep brain stimulation for Parkinson disease

Neurology

Volumn 84, Issue 13, 2015, Pages 1355-1361

  Odekerken, Vincent J J ^a   Boel, Judith A ^a,b   Geurtsen, Gert J ^a   Schmand, Ben A ^a,b   Dekker, I P ^a   De Haan, Rob J ^a   Schuurman, P Richard ^a   De Bie, Rob M A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CONTROLLED STUDY; DISEASE DURATION; DUTCH ADULT READING TEST; EXECUTIVE FUNCTION; FEMALE; GLOBUS PALLIDUS PARS INTERNA; GLOBUS PALLIDUS PARS INTERNA BRAIN DEPTH STIMULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATTIS DEMENTIA RATING SCALE; MENTAL DETERIORATION; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REY AUDITORY VERBAL LEARNING TEST; RIVERMEAD BEHAVIORAL MEMORY TEST; SEMANTICS; STROOP TEST; SUBTHALAMIC NUCLEUS; SUBTHALAMIC NUCLEUS BRAIN DEPTH STIMULATION; UNIFIED PARKINSON DISEASE RATING SCALE; WECHSLER INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST; ADVERSE EFFECTS; COGNITIVE DEFECT; COMPARATIVE STUDY; COMPLICATION; DOUBLE BLIND PROCEDURE; GLOBUS PALLIDUS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

COGNITION DISORDERS; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; GLOBUS PALLIDUS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84931073689     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001419     Document Type: Article

References (28)

1. Vidailhet M. Movement disorders in 2010: Parkinson disease: symptoms and treatments. Nat Rev Neurol 2011;7: 70-72.
2. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554-560.
3. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
4. Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
5. Okun MS, Foote KD. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch Neurol 2005;62:533-536.
6. Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry 2011;82:754-760.
7. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
9. Mattis S. Dementia Rating Scale Professional Manual. Odessa, FL: Psychological Assessment Resources; 1973.
10. Schmand B, Lindeboom J, van Harskamp F. Nederlandse Leestest Voor Volwassenen (Dutch Adult Reading Test). Lisse, the Netherlands: Swets and Zeitlinger; 1992.
11. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;1935:643-662.
12. Reitan RM. Trail Making Test Manual for Administration and Scoring. Tucson, AZ: Reitan Neuropsychological Laboratory; 1992.
13. Wechsler D. WAIS-III Administration and Scoring Manual. San Antonio: The Psychological Corporation; 1997.
14. Schuhfried GmbH. Vienna Test System, RT Reaction Test. Moedling, Austria: 2004.
15. Alpherts WCJ, Aldenkamp AP. Fepsy. Heemstede: Instituut voor epilepsiebestrijding; 1994.
16. Rosen WG. Verbal fluency in aging and dementia. J Clin Neuropsychol 1980;2:135-146.
17. Kaplan EG, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea and Febiger; 2005.
18. Rey A. l'Éxamen Clinique en Psychologie. Paris: Presses Universitaires de France; 1964.
19. Wilson B, Cockburn J, Baddeley AD. The Rivermead Behavioral Memory Test. Reading, UK: Thames Valley Test Company; 1985.
20. de Boer AG,Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-74.
21. Cohen JD. Statistical Power Analysis for the Behavioral Science. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
22. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
23. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
24. Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological Assessment. New York: Oxford University Press; 2012.
25. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-207.
26. Rothlind JC, York MK, Carlson K, et al. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry Epub 2014 Sep 2.
27. Williams NR, Foote KD, Okun MS. STN vs. GPi deep brain stimulation: translating the rematch into clinical practice. Mov Disord Clin Pract 2014;1:24-35.
28. Yaguez L, Costello A, Moriarty J, et al. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease. J Clin Neurosci 2014;21:445-450.